POST Online Media Lite Edition


BrightSpec appoints R. Terry Dunlay to board

Christian Fernsby |
Charlottesville, Va., USA - BrightSpec, a life science instrumentation company, announced the appointment of R. Terry Dunlay to the board of directors.

Article continues below

Mr. Dunlay brings more than 30 years of life science industry experience.

Mr. Dunlay was the founder and CEO of IntelliCyt Corporation which developed instrumentation, software, and reagents for immunology and immuno-oncology applications.

Prior to founding IntelliCyt, Mr. Dunlay was cofounder of Cellomics, a Pittsburgh, PA based automated cellular analysis company.

Subsequent to his operating roles, he has remained active in the life science industry through directorships (Mindset Integrated, Wavefront Dynamics, and BennuBio).